Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiaoling Cheng

Showing results (111-120 of 147) with videos related to

Pageof 15
Sort By:
Clinical Therapeutics|October 17, 2024
Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Moderate or Severe Hemophilia A in ChinaYaohan Zhou, Zhengping Li, Guoqing Liu, et al.
American Journal of Hematology|December 18, 2024
Clinical Use of Eltrombopag and Avatrombopag in Pediatric ITP in China: A Real-World Multicenter Retrospective Cohort StudyJingjing Liu, Zhifa Wang, Nan Wang, et al.
Pediatric Blood & Cancer|October 3, 2022
Anaplastic lymphoma kinase positive histiocytosis presenting as hemocytopenia in an infantWenqian Wang, Lejian He, Runhui Wu, et al.
International Journal of Clinical and Experimental Medicine|November 10, 2015
Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in ChinaYanhui Lu, Minyan Liu, Yu Pei, et al.
Research and Practice in Thrombosis and Haemostasis|April 1, 2025
Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from ChinaLingling Fu, Xi Lin, Zhenping Chen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2022
Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in ChinaZekun Li, Guoqing Liu, Wanru Yao, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitorsZekun Li, Zhenping Chen, Guoqing Liu, et al.
Journal of Medicinal Chemistry|July 8, 2026
Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer TreatmentWeiji Chen, Xiaoling Cheng, Xi Zhao, et al.
Frontiers in Pharmacology|December 6, 2021
Detection of Drug-Induced Thrombocytopenia Signals in Children Using Routine Electronic Medical RecordsXiaolu Nie, Lulu Jia, Xiaoxia Peng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 6, 2025
Mechanism of Eucalyptus oil in alleviating UUO-induced renal fibrosis revealed by transcriptomics and metabolomicsNa Li, Huili Qi, Jiacun Li, et al.
Pageof 15

Showing results (111-120 of 147) with videos related to

Sort By:
Pageof 15
Clinical Therapeutics|October 17, 2024
Cost-effectiveness Analysis of Prophylaxis Versus On-demand Treatment for Children With Moderate or Severe Hemophilia A in ChinaYaohan Zhou, Zhengping Li, Guoqing Liu, et al.
American Journal of Hematology|December 18, 2024
Clinical Use of Eltrombopag and Avatrombopag in Pediatric ITP in China: A Real-World Multicenter Retrospective Cohort StudyJingjing Liu, Zhifa Wang, Nan Wang, et al.
Pediatric Blood & Cancer|October 3, 2022
Anaplastic lymphoma kinase positive histiocytosis presenting as hemocytopenia in an infantWenqian Wang, Lejian He, Runhui Wu, et al.
International Journal of Clinical and Experimental Medicine|November 10, 2015
Low levels of serum 25-hydroxyvitamin D and risk of metabolic syndrome in ChinaYanhui Lu, Minyan Liu, Yu Pei, et al.
Research and Practice in Thrombosis and Haemostasis|April 1, 2025
Stepwise response-guided treatment protocol superior to thrombopoietin receptor agonist-based second-line therapy for severe persistent/chronic immune thrombocytopenia: a multicenter prospective study from ChinaLingling Fu, Xi Lin, Zhenping Chen, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 3, 2022
Eradication of FIX inhibitor in haemophilia B children using low-dose immune tolerance induction with rituximab-based immunosuppressive agent(s) in ChinaZekun Li, Guoqing Liu, Wanru Yao, et al.
Research and Practice in Thrombosis and Haemostasis|July 19, 2021
Low-dose immune tolerance induction alone or with immunosuppressants according to prognostic risk factors in Chinese children with hemophilia A inhibitorsZekun Li, Zhenping Chen, Guoqing Liu, et al.
Journal of Medicinal Chemistry|July 8, 2026
Design, Synthesis, and Biological Evaluation of Novel PAK1/HDAC10 Dual Inhibitors That Activate Antitumor Immunity for Triple-Negative Breast Cancer TreatmentWeiji Chen, Xiaoling Cheng, Xi Zhao, et al.
Frontiers in Pharmacology|December 6, 2021
Detection of Drug-Induced Thrombocytopenia Signals in Children Using Routine Electronic Medical RecordsXiaolu Nie, Lulu Jia, Xiaoxia Peng, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|August 6, 2025
Mechanism of Eucalyptus oil in alleviating UUO-induced renal fibrosis revealed by transcriptomics and metabolomicsNa Li, Huili Qi, Jiacun Li, et al.
Pageof 15